OncoPeptTUME – An in silico platform to study tumor micro-environment
Cancer immunotherapy is now established as a major therapeutic modality, and 70% of all cancer patients are estimated to receive some form of an immunotherapy treatment as a part of their disease control by 2025. Several different tumor cell-intrinsic and extrinsic features including the tumor micro...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Science Planet Inc.
2017-12-01
|
Series: | Canadian Journal of Biotechnology |
Online Access: | https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue-Supplement/cjb.2017-a207.pdf |